Efficacy and safety of dostarlimab in combination with chemotherapy in patients with dMMR/MSI-H primary advanced or recurrent endometrial cancer in a phase 3, randomized, placebo-controlled trial (ENGOT-EN6-NSGO/GOG-3031/RUBY)

Powell, Matthew A.; Cibula, David; O'Malley, David M.; Boere, Ingrid; Shahin, Mark S.; Savarese, Antonella; Chase, Dana M.; Gilbert, Lucy; Black, Destin; Herrstedt, Jorn; Sharma, Sudarshan; Kommoss, Stefan; Gold, Michael A.; Thijs, Anna M.; Ring, Kari; Bolling, Magnus Frodin; Buscema, Joseph; Gill, Sarah E.; Nowicki, Paul; Nevadunsky, Nicole; Callahan, Michael; Willmott, Lyndsay; McCourt, Carolyn; Billingsley, Caroline; Ghamande, Sharad A.; He, Zangdong; Balas, Morad Marco; Stevens, Shadi; Fleming, Evelyn; Mirza, Mansoor Raza

Efficacy and safety of dostarlimab in combination with chemotherapy in patients with dMMR/MSI-H primary advanced or recurrent endometrial cancer in a phase 3, randomized, placebo-controlled trial (ENGOT-EN6-NSGO/GOG-3031/RUBY)

Autor(en):

Powell, Matthew A.; Cibula, David; O'Malley, David M.; Boere, Ingrid; Shahin, Mark S.; Savarese, Antonella; Chase, Dana M.; Gilbert, Lucy; Black, Destin; Herrstedt, Jorn; Sharma, Sudarshan; Kommoss, Stefan; Gold, Michael A.; Thijs, Anna M.; Ring, Kari; Bolling, Magnus Frodin; Buscema, Joseph; Gill, Sarah E.; Nowicki, Paul; Nevadunsky, Nicole; Callahan, Michael; Willmott, Lyndsay; McCourt, Carolyn; Billingsley, Caroline; Ghamande, Sharad A.; He, Zangdong; Balas, Morad Marco; Stevens, Shadi; Fleming, Evelyn; Mirza, Mansoor Raza

Tübinger Autor(en):

Kommoss, Stefan

Erschienen in:

Gynecologic Oncology (2025), Bd. 192, S. 40-49

Verlagsangabe:

San Diego : Academic Press Inc Elsevier Science

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1016/j.ygyno.2024.10.022

ISSN:

0090-8258